etalpha 0.5 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.5 mikrog
rocaltrol 0.25 mikrog
2care4 aps - kalsitriol - kapsel, myk - 0.25 mikrog
rocaltrol 0.25 mikrog
2care4 aps - kalsitriol - kapsel, myk - 0.25 mikrog
rocaltrol 0.25 mikrog
2care4 aps - kalsitriol - kapsel, myk - 0.25 mikrog
erivedge 150 mg
orifarm as - vismodegib - kapsel, hard - 150 mg
erivedge 150 mg
2care4 aps - vismodegib - kapsel, hard - 150 mg
jevtana 60 mg
orifarm as - kabazitaksel - konsentrat og væske til infusjonsvæske, oppløsning - 60 mg
erivedge 150 mg
abacus medicine a/s - vismodegib - kapsel, hard - 150 mg
lumykras
amgen europe bv - sotorasib - karsinom, ikke-småcellet lunge - antineoplastiske midler - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
cometriq
ipsen pharma - cabozantinib - skjoldbrusk neoplasmer - antineoplastiske midler - behandling av voksne pasienter med progressiv, uoppløselig lokalt avansert eller metastatisk medulær skjoldbrusk-karsinom.